New Cancer Antibody Approved by Brazil’s Anvisa
Lung Cancer Treatment Enters a New Era: The Promise of Antibody Therapies and Personalized Medicine Every two minutes, someone in the United States receives a lung cancer diagnosis. But a recent approval by Brazil’s Anvisa signals a potential turning point in the fight against this devastating disease. While the immediate news focuses on a new … Read more
